Netherland-based Royal Philips has introduced its IntelliVue patient monitoring platform with Masimo rainbow SET technology.
As well as offering its customers the option to add rainbow SET to existing IntelliVue monitors, Philips is working to integrate the technology into its SureSigns and Efficia patient monitoring platforms.
The IntelliVue MP90 patient monitor has been designed to cater to fast-paced acute care environments. It offers event surveillance, parameter histograms, sepsis screening, and diverse clinical measurements to support informed decisions.
Masimo rainbow SET technology, in conjunction with the Philips patient monitoring platform, analyses multiple wavelengths of light to accurately measure total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and Pleth Variability Index (PVI) noninvasively and continuously.
The continuous monitoring of rainbow SpHb on a Philips monitor at the point-of-care offers clinicians with a real-time visibility to track the changes in hemoglobin in between invasive blood sampling.
Philips continues to offer Philips FAST SpO2 pulse oximetry and Covidien’s OxiMax SpO2 pulse oximetry, based on the patient monitoring platform in order to provide customers the choice of SpO2 pulse oximetry measurement technology.
The firm offers a range of patient monitoring solutions including bedside monitors, wearable patient monitors along with clinical decision support tools and mobile applications, to provide immediate access to centrally held patient data.
In 2014, over 275 million patients were monitored with Philips’ patient monitors.
